her2 cancer treatment - resistance, immunologic implications, and biosimilars
Published 4 years ago • 5 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
4:34
her2 cancer treatment - resistance, immunologic implications, and biosimilars.mp4
-
5:15
mechanisms and implications of her2 resistance - an interview with dr. william gradishar
-
5:21
mechanisms and implications of her2 resistance - an interview with dr. william gradishar.mp4
-
7:46
practical considerations in integrating her2 biosimilars in clinical practice
-
4:37
combating 'financial toxicity' - her2 biosimilars and combinations with chemotherapy.mp4
-
7:40
practical considerations in integrating her2 biosimilars in clinical practice
-
0:36
how is her2 positive breast cancer treated? #shorts
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
0:31
get to know her2-positive breast cancer and its targeted treatments
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
0:58
enhertu therapy: a powerful new cancer treatment
-
11:12
her2-low breast cancer: destiny or good science?
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
0:39
science behind nfκb activation in her2 breast cancer & its link with inflammation & cancer #her2
-
0:39
what is her2 in #breastcancer?
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
0:50
what is her2 breast cancer? #shorts
-
0:39
understanding the role of mip-1b cytokine in her2 positive breast cancer. #mip1b #her2